Addison’s Disease Drugs Market, Global Outlook and Forecast 2022-2028

January 2022 | 107 pages | ID: A8E2DFDFB802EN
Market Monitor Global

Abstracts

Some options for treatment include oral corticosteroids such as: Hydrocortisone (Cortef), prednisone or methylprednisolone to replace cortisol.

This report contains market size and forecasts of Addison’s Disease Drugs in Global, including the following market information:

Global Addison’s Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Addison’s Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Addison’s Disease Drugs include Bristol-Myers Squibb, Merck, Novartis, Pfizer, Takeda Pharmaceutical, Bio-Techne, GlaxoSmithKline, Lupin Pharmaceuticals and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Addison’s Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Addison’s Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Addison’s Disease Drugs Market Segment Percentages, by Type, 2021 (%)

• Oral Drugs
• Parenteral Drugs

Global Addison’s Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Addison’s Disease Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics

Global Addison’s Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Addison’s Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Addison’s Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Addison’s Disease Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb
• Merck
• Novartis
• Pfizer
• Takeda Pharmaceutical
• Bio-Techne
• GlaxoSmithKline
• Lupin Pharmaceuticals
• Abbott
• Amgen
• Bayer
• Biogen
• Eli Lilly and Company
• Boehringer Ingelheim International
• Diurnal
• Switzer Life Science
• Recipharm

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Addison’s Disease Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Addison’s Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADDISON’S DISEASE DRUGS OVERALL MARKET SIZE

2.1 Global Addison’s Disease Drugs Market Size: 2021 VS 2028
2.2 Global Addison’s Disease Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Addison’s Disease Drugs Players in Global Market
3.2 Top Global Addison’s Disease Drugs Companies Ranked by Revenue
3.3 Global Addison’s Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Addison’s Disease Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Addison’s Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Addison’s Disease Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Addison’s Disease Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Addison’s Disease Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Addison’s Disease Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oral Drugs
  4.1.3 Parenteral Drugs
4.2 By Type - Global Addison’s Disease Drugs Revenue & Forecasts
  4.2.1 By Type - Global Addison’s Disease Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Addison’s Disease Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Addison’s Disease Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Addison’s Disease Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
5.2 By Application - Global Addison’s Disease Drugs Revenue & Forecasts
  5.2.1 By Application - Global Addison’s Disease Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Addison’s Disease Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Addison’s Disease Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Addison’s Disease Drugs Market Size, 2021 & 2028
6.2 By Region - Global Addison’s Disease Drugs Revenue & Forecasts
  6.2.1 By Region - Global Addison’s Disease Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Addison’s Disease Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Addison’s Disease Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Addison’s Disease Drugs Revenue, 2017-2028
  6.3.2 US Addison’s Disease Drugs Market Size, 2017-2028
  6.3.3 Canada Addison’s Disease Drugs Market Size, 2017-2028
  6.3.4 Mexico Addison’s Disease Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Addison’s Disease Drugs Revenue, 2017-2028
  6.4.2 Germany Addison’s Disease Drugs Market Size, 2017-2028
  6.4.3 France Addison’s Disease Drugs Market Size, 2017-2028
  6.4.4 U.K. Addison’s Disease Drugs Market Size, 2017-2028
  6.4.5 Italy Addison’s Disease Drugs Market Size, 2017-2028
  6.4.6 Russia Addison’s Disease Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Addison’s Disease Drugs Market Size, 2017-2028
  6.4.8 Benelux Addison’s Disease Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Addison’s Disease Drugs Revenue, 2017-2028
  6.5.2 China Addison’s Disease Drugs Market Size, 2017-2028
  6.5.3 Japan Addison’s Disease Drugs Market Size, 2017-2028
  6.5.4 South Korea Addison’s Disease Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Addison’s Disease Drugs Market Size, 2017-2028
  6.5.6 India Addison’s Disease Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Addison’s Disease Drugs Revenue, 2017-2028
  6.6.2 Brazil Addison’s Disease Drugs Market Size, 2017-2028
  6.6.3 Argentina Addison’s Disease Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Addison’s Disease Drugs Revenue, 2017-2028
  6.7.2 Turkey Addison’s Disease Drugs Market Size, 2017-2028
  6.7.3 Israel Addison’s Disease Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Addison’s Disease Drugs Market Size, 2017-2028
  6.7.5 UAE Addison’s Disease Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bristol-Myers Squibb
  7.1.1 Bristol-Myers Squibb Corporate Summary
  7.1.2 Bristol-Myers Squibb Business Overview
  7.1.3 Bristol-Myers Squibb Addison’s Disease Drugs Major Product Offerings
  7.1.4 Bristol-Myers Squibb Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.1.5 Bristol-Myers Squibb Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Addison’s Disease Drugs Major Product Offerings
  7.2.4 Merck Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Addison’s Disease Drugs Major Product Offerings
  7.3.4 Novartis Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Addison’s Disease Drugs Major Product Offerings
  7.4.4 Pfizer Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Takeda Pharmaceutical
  7.5.1 Takeda Pharmaceutical Corporate Summary
  7.5.2 Takeda Pharmaceutical Business Overview
  7.5.3 Takeda Pharmaceutical Addison’s Disease Drugs Major Product Offerings
  7.5.4 Takeda Pharmaceutical Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.5.5 Takeda Pharmaceutical Key News
7.6 Bio-Techne
  7.6.1 Bio-Techne Corporate Summary
  7.6.2 Bio-Techne Business Overview
  7.6.3 Bio-Techne Addison’s Disease Drugs Major Product Offerings
  7.6.4 Bio-Techne Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.6.5 Bio-Techne Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Addison’s Disease Drugs Major Product Offerings
  7.7.4 GlaxoSmithKline Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Lupin Pharmaceuticals
  7.8.1 Lupin Pharmaceuticals Corporate Summary
  7.8.2 Lupin Pharmaceuticals Business Overview
  7.8.3 Lupin Pharmaceuticals Addison’s Disease Drugs Major Product Offerings
  7.8.4 Lupin Pharmaceuticals Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.8.5 Lupin Pharmaceuticals Key News
7.9 Abbott
  7.9.1 Abbott Corporate Summary
  7.9.2 Abbott Business Overview
  7.9.3 Abbott Addison’s Disease Drugs Major Product Offerings
  7.9.4 Abbott Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.9.5 Abbott Key News
7.10 Amgen
  7.10.1 Amgen Corporate Summary
  7.10.2 Amgen Business Overview
  7.10.3 Amgen Addison’s Disease Drugs Major Product Offerings
  7.10.4 Amgen Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.10.5 Amgen Key News
7.11 Bayer
  7.11.1 Bayer Corporate Summary
  7.11.2 Bayer Business Overview
  7.11.3 Bayer Addison’s Disease Drugs Major Product Offerings
  7.11.4 Bayer Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.11.5 Bayer Key News
7.12 Biogen
  7.12.1 Biogen Corporate Summary
  7.12.2 Biogen Business Overview
  7.12.3 Biogen Addison’s Disease Drugs Major Product Offerings
  7.12.4 Biogen Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.12.5 Biogen Key News
7.13 Eli Lilly and Company
  7.13.1 Eli Lilly and Company Corporate Summary
  7.13.2 Eli Lilly and Company Business Overview
  7.13.3 Eli Lilly and Company Addison’s Disease Drugs Major Product Offerings
  7.13.4 Eli Lilly and Company Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.13.5 Eli Lilly and Company Key News
7.14 Boehringer Ingelheim International
  7.14.1 Boehringer Ingelheim International Corporate Summary
  7.14.2 Boehringer Ingelheim International Business Overview
  7.14.3 Boehringer Ingelheim International Addison’s Disease Drugs Major Product Offerings
  7.14.4 Boehringer Ingelheim International Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.14.5 Boehringer Ingelheim International Key News
7.15 Diurnal
  7.15.1 Diurnal Corporate Summary
  7.15.2 Diurnal Business Overview
  7.15.3 Diurnal Addison’s Disease Drugs Major Product Offerings
  7.15.4 Diurnal Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.15.5 Diurnal Key News
7.16 Switzer Life Science
  7.16.1 Switzer Life Science Corporate Summary
  7.16.2 Switzer Life Science Business Overview
  7.16.3 Switzer Life Science Addison’s Disease Drugs Major Product Offerings
  7.16.4 Switzer Life Science Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.16.5 Switzer Life Science Key News
7.17 Recipharm
  7.17.1 Recipharm Corporate Summary
  7.17.2 Recipharm Business Overview
  7.17.3 Recipharm Addison’s Disease Drugs Major Product Offerings
  7.17.4 Recipharm Addison’s Disease Drugs Revenue in Global Market (2017-2022)
  7.17.5 Recipharm Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Addison’s Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Addison’s Disease Drugs Market Drivers in Global Market
Table 3. Addison’s Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Addison’s Disease Drugs in Global Market
Table 5. Top Addison’s Disease Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Addison’s Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Addison’s Disease Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Addison’s Disease Drugs Product Type
Table 9. List of Global Tier 1 Addison’s Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Addison’s Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Addison’s Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Addison’s Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Addison’s Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Addison’s Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Addison’s Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Addison’s Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Addison’s Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Addison’s Disease Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Addison’s Disease Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Addison’s Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Addison’s Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Addison’s Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Addison’s Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Addison’s Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Bristol-Myers Squibb Corporate Summary
Table 31. Bristol-Myers Squibb Addison’s Disease Drugs Product Offerings
Table 32. Bristol-Myers Squibb Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Addison’s Disease Drugs Product Offerings
Table 35. Merck Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Addison’s Disease Drugs Product Offerings
Table 38. Novartis Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Addison’s Disease Drugs Product Offerings
Table 41. Pfizer Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Pharmaceutical Corporate Summary
Table 43. Takeda Pharmaceutical Addison’s Disease Drugs Product Offerings
Table 44. Takeda Pharmaceutical Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Bio-Techne Corporate Summary
Table 46. Bio-Techne Addison’s Disease Drugs Product Offerings
Table 47. Bio-Techne Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Addison’s Disease Drugs Product Offerings
Table 50. GlaxoSmithKline Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Lupin Pharmaceuticals Corporate Summary
Table 52. Lupin Pharmaceuticals Addison’s Disease Drugs Product Offerings
Table 53. Lupin Pharmaceuticals Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Corporate Summary
Table 55. Abbott Addison’s Disease Drugs Product Offerings
Table 56. Abbott Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Amgen Corporate Summary
Table 58. Amgen Addison’s Disease Drugs Product Offerings
Table 59. Amgen Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Bayer Corporate Summary
Table 61. Bayer Addison’s Disease Drugs Product Offerings
Table 62. Bayer Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Biogen Corporate Summary
Table 64. Biogen Addison’s Disease Drugs Product Offerings
Table 65. Biogen Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Eli Lilly and Company Corporate Summary
Table 67. Eli Lilly and Company Addison’s Disease Drugs Product Offerings
Table 68. Eli Lilly and Company Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Boehringer Ingelheim International Corporate Summary
Table 70. Boehringer Ingelheim International Addison’s Disease Drugs Product Offerings
Table 71. Boehringer Ingelheim International Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Diurnal Corporate Summary
Table 73. Diurnal Addison’s Disease Drugs Product Offerings
Table 74. Diurnal Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Switzer Life Science Corporate Summary
Table 76. Switzer Life Science Addison’s Disease Drugs Product Offerings
Table 77. Switzer Life Science Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Recipharm Corporate Summary
Table 79. Recipharm Addison’s Disease Drugs Product Offerings
Table 80. Recipharm Addison’s Disease Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Addison’s Disease Drugs Segment by Type in 2021
Figure 2. Addison’s Disease Drugs Segment by Application in 2021
Figure 3. Global Addison’s Disease Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Addison’s Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Addison’s Disease Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Addison’s Disease Drugs Revenue in 2021
Figure 8. By Type - Global Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 12. US Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 24. China Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Addison’s Disease Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Addison’s Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol-Myers Squibb Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Pharmaceutical Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bio-Techne Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lupin Pharmaceuticals Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amgen Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Biogen Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Eli Lilly and Company Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Boehringer Ingelheim International Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Diurnal Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Switzer Life Science Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Recipharm Addison’s Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)